Discovery shows promise for treating Huntington’s Disease

Scientists at the lab of Professor Hilal Lashuel at EPFL have identified a new enzyme called “TBK1” who plays a central role in regulating the degradation and clearance of the huntingtin protein and introduces chemical modifications that block its aggregation. “We believe that this represents a viable target for the development of possible treatment of Huntington’s disease,” says Lashuel.